(Q48738221)

15 February 2018

reason for preferred rank

title

Plasma and CSF levels of dizocilplne (MK-801) required for neuroprotection in the quinolinate-injected rat striatum (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

5 December 2022

Plasma and CSF levels of dizocilpine (MK-801) required for neuroprotection in the quinolinate-injected rat striatum (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832637

5 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

5 December 2022

author name string

C. L. Willis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832637

5 December 2022

C. Brazell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832637

5 December 2022

A. C. Foster

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832637

5 December 2022

language of work or name

English

0 references

publication date

1 April 1991

1 reference

15 February 2018

24 April 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1832637

full work available at URL

5 December 2022

https://api.elsevier.com/content/article/PII:001429999190441R?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

https://api.elsevier.com/content/article/PII:001429999190441R?httpAccept=text/plain

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

European Journal of Pharmacology

5 December 2022

published in

1 reference

15 February 2018

volume

196

1 reference

15 February 2018

issue

3

1 reference

15 February 2018

page(s)

285-290

1 reference

15 February 2018

The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Standardization of a radiochemical assay of choline acetyltransferase and a study of the activation of the enzyme in rabbit brain.

5 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Glutamate neurotoxicity in cortical cell culture is calcium dependent

5 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Glutamate neurotoxicity and diseases of the nervous system

5 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

The role of excitatory amino acids and NMDA receptors in traumatic brain injury

5 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Amino acid neurotransmitters and their pathways in the mammalian central nervous system

5 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Glutamate: A Neurotransmitter in Mammalian Brain

5 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.

5 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Protection Against N-methyl-D-aspartate Receptor-Mediated Neuronal Degeneration In Rat Brain by 7-chlorokynurenate and 3-amino-1-hydroxypyrrolid-2-one, Antagonists at The Allosteric Site for Glycine.

5 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil.

5 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period

5 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

A radioimmunoassay for the anticonvulsant and neuroprotective agent, MK-801

5 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones

5 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system

5 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Magnesium gates glutamate-activated channels in mouse central neurones

5 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat

5 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Delayed hippocampal damage in humans following cardiorespiratory arrest.

5 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Temporal profile of neuronal damage in a model of transient forebrain ischemia

5 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Delayed neurotoxicity of excitatory amino acids in vitro.

5 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Determination of brain 5-hydroxytryptamine turnover in freely moving rats using repeated sampling of cerebrovascular fluid

5 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Excitatory aminoacid antagonists provide a therapeutic approach to neurological disorders.

5 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

5 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

5 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

5 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Synthesis and pharmacological evaluation of a series of dibenzo[a,d]cycloalkenimines as N-methyl-D-aspartate antagonists

5 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats

5 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Excitatory Amino Acid Transmitters

5 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist.

5 December 2022

31

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

5 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

[3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes.

5 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90441-R

5 December 2022

Identifiers

1 reference

15 February 2018

1 reference

15 February 2018